Pas 16
Pas 16
PPE are:
Capitalization of costs ceases when the PPE is in the location and condition
necessary for it to be capable of operating in the manner intended by
management. Therefore, costs incurred in using or redeploying a PPE are
not capitalized.
a. Replacement costs – some PPE have parts that need to be replaced, e.g., the
seats in an aircraft. The cost of replacing a part of an item of PPE is
capitalized if the recognition criteria are met. The carrying amount of the
replaced part (old part) is derecognized and charged as loss, regardless of
whether it had been depreciated separately or not. If the carrying amount of
the replaced part cannot be determined, the cost of the replacement part
(new part is used as an indication of what the cost of the replaced part was
at the time it was acquired or constructed.
Cost 1,000,000
Less: Residual value (50,000)
Depreciable amount 950,000
Divide by: Useful life 5
Annual depreciation 190,000
The carrying amount of the equipment at the end of 20x1 is
computed as follows:
Cost 1,000,000
Accumulated depreciation (190,000 x 1yr) 190,000
Carrying amount – 12/31/20x1 810,000
For example, if an entity revalues a bearer plant, it must revalue all of its
bearer plants. Moreover, all the bearer plants are revalued simultaneously to
avoid selective revaluation. If simultaneous is not possible, the revaluation may
be carried out on a rolling basis (i.e., one asset after another) provided the
revaluation of all the assets within the class is completed within a short period.
Accounting for Revaluations
Fair value* xx
Less: Carrying amount (xx)
Revaluation surplus xx
Alternative solution:
(2,000,000 revaluation surplus / 10 years) = 200,000
Special case:
Some entities, in the ordinary course of their activities, routinely
manufacture or acquire items of PPE to be held for rental to others
and subsequently transfer these assets to inventories when they
cease to be rented and become held for sale. For these entities, the
proceeds from the sale of such assets are recognized as revenue.
Illustration:
There is gain because the net selling price exceeds the carrying
amount.
Disclosure
Additional disclosures:
f. Restrictions on title and PPE pledged as security for liabilities
g. Expenditures to construct PPE during the period
h. Contractual commitments for the acquisition of PPE
i. Compensation for impairment losses
j. Changes in estimates relating to PPE
Disclosures for revalued PPE:
a. Date of the revaluation
b. Whether an independent valuer was involved
c. The carrying amount of each revalued class of PPE if they had been
measured under the cost model
d. Revaluation surplus, including changes during the period and any
restrictions on its distribution to shareholders.
Encouraged disclosures:
e. Carrying amount of temporarily idle PPE
f. Gross carrying amount of any fully depreciated PPE that is still in
use
g. Carrying amount of PPE retired from active use and not classified as
held for sale in accordance with PFRS 5
h. When the cost model is used, the fair value of PPE when this is
materially different from the carrying amount